Zhongchao Inc

Zhongchao Inc(ZCMD)股票分析

$0.965

+0.007 (+0.73%)收盘时

Loading chart…
最高
1.035
开盘
0.946
成交量加权均价
0.98
成交量
91.16K
市值
3.23M
最低
0.946
成交额
89.54K
企业价值/息税折旧摊销前利润(TTM)
0.00

Zhongchao Inc is a holding company primarily engaged in the provision of healthcare information, education, and training services to healthcare professionals and the public. The Company is primarily engaged in the provision of medical training and education services and assistance in patient-aid projects through MDMOOC online platform and offline formats. The MDMOOC online platform includes MDMOOC mobile application (App), MOOC Medical WeChat subscription account, and MDMOOC website. Under the MDMOOC brand, the Company provides various online and onsite health information services, healthcare education programs, and healthcare training products, consisting primarily of clinical practice training, open classes of medical topics, interactive case studies, academic conference and workshops, continuing education courses, and articles and short videos with educational healthcare content. The Company primarily operates its businesses in the domestic market.

AI 分析 of Zhongchao Inc (ZCMD)

持有

Zhongchao Inc. (ZCMD) currently trades at $0.97, which is significantly down 99.87% year-to-date and 99.90% over the past year, indicating severe long-term underperformance. The RSI is at 30.86, suggesting it is oversold, but the forward P/E is 0, indicating no expected earnings growth. The company's gross margin is relatively strong at 55.5%, but it reported a net income loss of $733,276 in the last quarter. The main risk is the company's drastic decline in stock price, which has fallen 39.29% over the last 20 days, reflecting ongoing investor concerns about its viability. Given these factors, it is prudent to hold rather than buy at this time.

估值指标

Zhongchao Inc(ZCMD)当前预期市盈率为 0.00,5 年平均预期市盈率为 0.00。

预期市盈率

严重低估
5 年均值 P/E
0.00
当前P/E
0.00
高估
0.00
低估
0.00

预期 EV/EBITDA

严重低估
5 年均值 EV/EBITDA
0.00
当前EV/EBITDA
0.00
高估
0.00
低估
0.00

预期市销率

严重低估
5 年均值 P/S
0.00
当前P/S
0.00
高估
0.00
低估
0.00

Alphio AI 对 ZCMD 的价格情景

情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

乐

乐观

乐观 · 25%ZCMD

$1.32

情景价格

基

基准

基准 · 50%ZCMD

$1.17

情景价格

悲

悲观

悲观 · 25%ZCMD

$1.00

情景价格

事件时间线

2026-09-30 (ET)

08:30:00

Zhongchao Announces 1-for-2 Share Consolidation

2026-07-23 (ET)

09:30:00

Zhongchao Enters Agreement to Issue 4.55 Million Shares at $1.10

2026-06-25 (ET)

08:31:00

Zhongchao to Effectuate 1-for-3 Share Consolidation

2026-05-07 (ET)

14:50:00

Zhongchao Plans Best-Efforts Offering of 5.56M Units

2026-02-26 (ET)

08:50:00

Zhongchao to Effectuate 1-for-8 Share Consolidation

资讯

ZCMD 常见问题 —— 由 Alphio AI 解答

Zhongchao Inc is a holding company primarily engaged in the provision of healthcare information, education, and training services to healthcare professionals and the public. The Company is primarily engaged in the provision of medical training and education services and assistance in patient-aid projects through MDMOOC online platform and offline formats. The MDMOOC online platform includes MDMOOC mobile application (App), MOOC Medical WeChat subscription account, and MDMOOC website. Under the MDMOOC brand, the Company provides various online and onsite health information services, healthcare education programs, and healthcare training products, consisting primarily of clinical practice training, open classes of medical topics, interactive case studies, academic conference and workshops, continuing education courses, and articles and short videos with educational healthcare content. The Company primarily operates its businesses in the domestic market. It operates in the Academic & Educational Services sector.

Zhongchao Inc. (ZCMD) currently trades at $0.97, which is significantly down 99.87% year-to-date and 99.90% over the past year, indicating severe long-term underperformance. The RSI is at 30.86, suggesting it is oversold, but the forward P/E is 0, indicating no expected earnings growth. The company's gross margin is relatively strong at 55.5%, but it reported a net income loss of $733,276 in the last quarter. The main risk is the company's drastic decline in stock price, which has fallen 39.29% over the last 20 days, reflecting ongoing investor concerns about its viability. Given these factors, it is prudent to hold rather than buy at this time.

暂无帖子

注册或登录后参与讨论

相关文章

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易